Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (23)

1

JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms

enthalten in: European journal of haematology | 2024

von Eickhardt-Dalbøge, C. | Nielsen, H. | Fuursted, K. | +15

2

CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties

enthalten in: Blood advances | 2024

von Hasselbalch, H. | Kristiansen, M. | Kjær, L. | +4

CommentOn: Blood Adv. 2023 Dec 12;7(23):7329-7330. - PMID 37956267

3

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis : a phase II study

enthalten in: Haematologica | 2020

von Sørensen, A. | Mikkelsen, S. | Knudsen, T. | +17

CommentIn: Haematologica. 2020 Jun 05;105(9):2190-2191. - PMID 33054041

4

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

enthalten in: Leukemia & lymphoma | 2019

von Holmström, M. | Novotny, G. | Petersen, J. | +6

5

Ruxolitinib treatment reduces monocytic superoxide radical formation without affecting hydrogen peroxide formation or systemic oxidative nucleoside damage in myelofibrosis

enthalten in: Leukemia & lymphoma | 2019

von Bjørn, M. | Brimnes, M. | Gudbrandsdottir, S. | +5

6

Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib

enthalten in: Expert review of hematology | 2017

von Bjørn, M. | Hasselbalch, H.

7

Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development

enthalten in: PloS one | 2017

von Andersen, M. | Sajid, Z. | Pedersen, R. | +10

8

Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia : a report on 12 Danish patients

enthalten in: Leukemia & lymphoma | 2016

von Bjørn, M. | Holmström, M. | Hasselbalch, H.

9

Status and perspectives on chronic myeloproliferative neoplasm treatment

enthalten in: Ugeskrift for laeger | 2015

von Ocias, L. | Holmström, M. | Riley, C. | +10

10

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

enthalten in: Leukemia research | 2013

von Stauffer Larsen, T. | Iversen, K. | Hansen, E. | +12